Danzi Gian Battista, Sesana Marco, Capuano Cinzia, Baglini Roberto, Bellosta Raffaello, Luzzani Luca, Carugati Claudio, Sarcina Antonio
Poliambulanza Hospital, Brescia, Italy.
Ital Heart J. 2005 May;6(5):384-9.
It has been shown that thrombin injection is a safe and effective technique for the treatment of iatrogenic femoral pseudoaneurysm. The aim of this study was to evaluate and compare the use of ultrasound-guided low-dose thrombin injections with ultrasonographically-guided compression repair in the treatment of iatrogenic femoral arterial pseudoaneurysm.
We compared two cohorts of patients treated for iatrogenic femoral pseudoaneurysm: the first included 38 patients who underwent ultrasonographically-guided compression repair as a first-step approach between January 1998 and November 2002; the second included 21 patients treated with ultrasound-guided low-dose thrombin injection between December 2002 and December 2003.
Both groups had similar demographic characteristics and aneurysm sizes (p = 0.72). Compression was successful in 24/38 patients (63%); the 14 persistent aneurysms were surgically repaired (37%). The primary thrombin injection of a mean dose of 185+/-95 U/ml (range 100-400 U/ml) successfully obliterated all of the 21 pseudoaneurysms (success rate 100 vs 63% in the compression group, p = 0.004). Thrombosis occurred within an average of 12+/-15 s of thrombin injection. Sedation was used in 42% of the patients undergoing compression and in none of those receiving thrombin (p = 0.001). The duration of hospitalization was significantly longer in patients undergoing compression therapy (9.8+/-5.6 vs 5.6+/-1.4 days, p = 0.001).
Ultrasound-guided low-dose thrombin injection appears to be more effective in reducing the need for surgical repair when used to treat iatrogenic femoral pseudoaneurysm, is better tolerated by the patients, and requires a shorter hospital stay.
已表明注射凝血酶是治疗医源性股动脉假性动脉瘤的一种安全有效的技术。本研究的目的是评估和比较超声引导下低剂量凝血酶注射与超声引导下压迫修复在医源性股动脉假性动脉瘤治疗中的应用。
我们比较了两组接受医源性股动脉假性动脉瘤治疗的患者:第一组包括1998年1月至2002年11月间作为第一步治疗方法接受超声引导下压迫修复的38例患者;第二组包括2002年12月至2003年12月间接受超声引导下低剂量凝血酶注射治疗的21例患者。
两组患者的人口统计学特征和动脉瘤大小相似(p = 0.72)。压迫修复在24/38例患者中成功(63%);14例持续性动脉瘤接受了手术修复(37%)。平均剂量为185±95 U/ml(范围100 - 400 U/ml)的初次凝血酶注射成功闭塞了所有21例假性动脉瘤(成功率100%,压迫修复组为63%,p = 0.004)。凝血酶注射后平均12±15秒内发生血栓形成。42%接受压迫修复的患者使用了镇静剂,而接受凝血酶注射的患者均未使用(p = 0.001)。接受压迫治疗的患者住院时间明显更长(9.8±5.6天对5.6±1.4天,p = 0.001)。
超声引导下低剂量凝血酶注射在治疗医源性股动脉假性动脉瘤时似乎在减少手术修复需求方面更有效,患者耐受性更好,且住院时间更短。